<DOC>
	<DOC>NCT00150241</DOC>
	<brief_summary>The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.</brief_summary>
	<brief_title>A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Subjects must have smoked on average of at least ten cigarettes per day during the past year Subjects must have no period of abstinence greater than three months in the past year Subjects with any history of cardiovascular disease Myocardial infarction Significant arrhythmias Poorly controlled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>